LATEST ALERTS
British American Tobacco (BAT) is pushing back to 2025 its goal of £5bn in revenues from its next-generation portfolio amid the COVID-19 pandemic and a decrease in heat-not-burn (HnB) business
Big Tobacco manufacturers are expecting the effects of COVID-19 to hit hard in the second half of the year, despite a strong performance in the first quarter
Swedish Match’s sales of smoke-free products boomed in the first quarter of 2020, with the segment recording a 35% year-on-year increase to SEK2.508bn (€234m)
Philip Morris International is braced for a significant dip in sales and use of its heated-tobacco device IQOS over the rest of 2020, with retail and travel restrictions currently imposed in nearly every country
British American Tobacco (BAT)’s “modern oral” portfolio has been one of the main drivers helping the company achieve good results in 2019 for its next-generation products category, which overall increased globally by 36.9%
PMI saw its market share of heated tobacco units in IQOS markets, excluding the US, rise by 1.4 percentage points to 5% last year, with a 44.2% increase in HnB shipments
Altria’s global net revenues rose 0.3% year-on-year in the third quarter of 2019 to $6.86bn, primarily due to higher net revenues in the smokeless products segment
The 2018 results from the Altria Group revealed a slump in sales of combustibles. The company is now turning its attention to alternative sectors such as cannabis and Juul, and preparing for the US launch of IQOS
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
